View Older Stories View More Recent Stories
-
Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
-
Celgene (CELG) PT Raised to $167 at BMO Capital on Positive Data from Phase STEPTONE Study of Ozanimod in Crohn's Disease
-
BMO Capital Starts Universal Forest Products (UFPI) at Market Perform
-
Netflix, Inc. (NFLX) Recap From The Sell-Side
-
Netflix (NFLX) PT Raised to $205 at BMO Capital
-
BMO Capital Starts Acadia Healthcare (ACHC) at Outperform
-
BMO Capital Starts Centene (CNC) at Outperform
-
BMO Capital Starts Humana (HUM) at Outperform
-
BMO Capital Starts Molina Healthcare (MOH) at Market Perform
-
BMO Capital Starts Anthem (ANTM) at Market Perform
-
BMO Capital Starts HCA Holdings (HCA) at Outperform
-
BMO Capital Starts Universal Health Services (UHS) at Outperform
-
ELS Reports Third Quarter Results
-
BMO Capital Starts Aetna (AET) at Market Perform
-
BMO Capital Starts Lifepoint Holdings (LPNT) at Market Perform
-
BMO Capital Starts Mednax (MD) at Market Perform
-
BMO Capital Starts CIGNA (CI) at Market Perform
-
BMO Capital Starts UnitedHealth Group (UNH) at Outperform
-
BMO Capital Starts WellCare Health Plans (WCG) at Outperform
-
Pre-Open Stock Movers 10/16: (TRXC) (RT) (EXEL) Higher; (AMPE) (ADBE) (ISRG) Lower (more...)
-
Impala Platinum Makes Strategic Investment to Advance Development of the Waterberg PGE Project
-
CGI and its Bank partners achieve ground-breaking interoperability between CGI Trade360 and Skuchain's blockchain platform
-
Alliance Data Top-Five Client Bank of Montreal Renews With LoyaltyOne®
-
BMO Capital Upgrades Five Prime Therapeutics (FPRX) to Outperform
-
OptiNose (OPTN) IPO Opens Higher
-
Gasoline boosts U.S. consumer prices, underlying inflation tame
-
Blackhawk Network (HAWK) PT Lowered to $51 at BMO Capital; 'Concerns Over U.S. Retail & Revenue Miss Overshadowed EPS Beat'
-
Wal-Mart (WMT) PT Raised to $91 at BMO Capital Following Analyst Meetings with Management
-
Citi (C) PT Raised to $67 at BMO Capital on 3Q Report; 'Top- and Bottom-Line Driven 4% Beat'
-
JPMorgan (JPM) PT Raised to $91 at BMO Capital on 3Q Beat; Top Line-Driven 5% Beat... Higher than Expected Revenues'
-
UPDATE: BMO Capital Downgrades Newfield Exploration (NFX) to Market Perform
-
IAC/InterActiveCorp (IAC) PT Raised to $160 at BMO Capital on Model Update; 'All Businesses at IAC on Positive Trajectories'
-
Match Group (MTCH): Raising Estimates & PT For Tinder - BMO
-
Spark Therapeutics (ONCE) PT Raised to $101 at BMO Capital
-
REV Group, Inc. (REVG) Prices 10M Share Secondary Common Offering at $27.25/Sh
-
Optinose Announces Pricing of Initial Public Offering
-
Switch, Inc. Announces Closing Of Initial Public Offering
-
REV Group, Inc. Announces Pricing of Secondary Offering of Common Stock
-
Pengrowth Announces Significant Debt Repayment and Finalization of Agreements With Bank Syndicate and Noteholders to Amend Financial Covenants
-
Drew Forman and Evan Karp Join Cowen’s Derivatives Sales and Trading Team
-
Juniper Networks (JNPR) PT Lowered to $31 at BMO Capital Following Pre-Announced 3Q
-
AveXis (AVXS): Data Could Support 2H18 Approval of AVXS-101 - BMO
-
Protagonist Therapeutics (PTGX) Prices 3.53M Share Common Offering at $17/Sh
-
Protagonist Therapeutics Prices Public Offering of Common Stock
-
Flexion Therapeutics (FLXN) Prices 4.8M Shares at $25.50
-
Flexion Therapeutics Announces Pricing of Public Offering of Common Stock
-
Protagonist Therapeutics (PTGX) Announces Proposed Common Share Offering
-
Protagonist Therapeutics Announces Proposed Public Offering of Common Stock
-
PlacementTracker Publishes Q3 2017 Private Placement Market League Tables
-
BMO Capital Downgrades Schlumberger (SLB) to Market Perform


